ArticleJournal of clinical medicine2022

Anlotinib Suppressed Ovarian Cancer Progression via Inducing G2/M Phase Arrest and Apoptosis.

Yanghui Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.